Jodie Ann Dionne
NIH Rank #1709
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11299422Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pediatrics
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$2.8M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#1,709
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Jodie Ann Dionne as a PI. Multi-PI records show the full award amount for context.
- 1U01AI195199-01U01Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs Benzathine Penicillin in Neonates with Possible Congenital Syphilis$2.3Maward amount
- 5R01AI176982-04R01Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection$451.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing Jodie Ann Dionne as a PI.
FY2026 award administered by University of Alabama at Birmingham (AL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Alabama at Birmingham
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #1709
- 2026Entered Top 25% NationallyRanked #1709
- 2026Entered Top 10% NationallyRanked #1709
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jodie Ann Dionne.